Form EFFECT Entasis Therapeutics
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | July 12, 2022 |
Accession Number: | 0001140361-22-025738 | ||||||
Submission Type: | POS AM | ||||||
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RUM Reports Annual Financial Results with Increased Net Comprehensive Income for the Year Ended December 31, 2023
- Credicorp Ltd.: Credicorp Raises Annual Dividend 40% to S/35.0 per Share
- Erie, Pittsburgh Injury Lawyer Legal Representation for Delayed Cancer Diagnosis
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!